In late 2022, Goldman Sachs began to pivot away from its consumer operations, beginning a series of write-downs related to selling chunks of the business.
Continue readingCategory Archives: Uncategorized
Big Lots files for bankruptcy protection, sells to private equity firm as it promises to keep offering ‘extreme bargains’
Discount home goods retailer Big Lots filed for bankruptcy protection as low-income shoppers slow spending on new furniture and home decor.
Continue readingNelson Peltz steps down as chair of Wendy’s board, starting a new era for burger chain
Peltz’s Trian Fund Management has a 10% stake in Wendy’s, making it the company’s second-largest shareholder.
Continue readingDirecTV customers will likely miss ‘Monday Night Football’ NFL game as carriage fight with Disney continues
DirecTV’s pay TV customers lost access to Disney’s networks, including ESPN, last week.
Continue readingNordstrom shares climb 5% as earnings top estimates, but retailer issues cautious guidance
Nordstrom has been working to cut costs and improve operations as it contends with softening demand for luxury goods.
Continue readingWashington Commanders strike stadium naming rights deal with Northwest Federal Credit Union
The home of the Washington, D.C., NFL team has been without a naming rights partner since FedEx ended its deal with the Commanders in February.
Continue readingNFL wants a cut of private equity investment profits
NFL owners are planning to vote on a proposal Tuesday that would allow private equity firms to take a maximum 10% stake in teams.
Continue readingHome prices hit record high in June on S&P Case-Shiller Index
On a three-month running average ending in June, prices nationally were 5.4% higher than they were in June 2023, according to data released Tuesday.
Continue readingNFL expected to vote in favor of private equity ownership; select firms to commit $12 billion
The NFL is the last major sports league to allow private equity investment as rising valuations make it harder for owners to buy in.
Continue readingEli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Eli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.
Continue reading